Table 1 Baseline demographic and clinical characteristics of patients in control vs intervention arm
Parameters | Control armb (N = 141) | Intervention armb (N = 139) |
|---|---|---|
Sex, n (%) female | 65 (46.0) | 59 (42.5) |
Age (years), median (IQR) | 10 (5–17) | 10 (5–14) |
Age groups | ||
 < 5 years, n (%) | 48 (34.0) | 35 (25.2) |
 5–14 years, n (%) | 49 (34.8) | 71 (51.1) |
 ≥ 15 years, n (%) | 44 (31.2) | 33 (23.7) |
Weight (kg), median (IQR) | 26 (16.5–49.5) | 27 (18–43) |
Screening P. falciparum parasitaemia (p/µL), geometric mean (95% CI) | 13,355 (9762–18,272) | 16,986 (12,936–22,305) |
Enrollment P. falciparum parasitaemia (p/µL), geometric mean (95% CI)a | 15,744 (10,949–2263) | 16,561 (11,812–23,219) |
Patients with P. falciparum gametocytaemia, n (%) | 3 (2.1) | 1 (0.7) |
Haemoglobin (g/dL), median (IQR) | 12.2 (10.6–13.3) | 12.0 (10.7–13.1) |
Fever (axillary temperature ≥ 37.5 °C), n (%) | 109 (77.3) | 110 (79.1) |
Axillary temperature (°C), median (IQR) | 38.4 (37.6–39.0) | 38.2 (37.7–39.1) |